Cardax Inc.

Cardax Inc.
Stock Exchange Other OTC
EPS
$0.03
Market Cap
$13.62 M
Shares Outstanding
136.02 M
Public Float
108.9 M

Profile

Address
2800 Woodlawn Drive
Honolulu Hawaii 96822
United States
Employees -
Website http://www.cardaxpharma.com
Updated 07/08/2019
Cardax, Inc. is a life sciences company, which engages in the development, marketing, and distribution of consumer health products. It focuses on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The company was founded on February 7, 2014 and is headquartered in Honolulu, HI.

Financials

View All

David G. Watumull
President, Chief Executive Officer & Director
Elona Kogan
Director